NCT07145788

Brief Summary

The current study investigates the effect of an integrative physiotherapy and mind-body program called PhYoMind intervention on disability and symptoms in individuals with fibromyalgia (FM). Participants will be randomized to either the PhYoMind intervention, which combines specific physiotherapy techniques with yoga and mindfulness, or to a home exercise control group. The intervention lasts 8 weeks, with supervised and home sessions. The primary outcome is disability, with secondary outcomes including measures of central and autonomic nervous system function, pain perception, stress, fatigue, and sleep quality. Adverse events and adherence of the intervention will be also assessed.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Feb 2026May 2026

First Submitted

Initial submission to the registry

August 12, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

February 10, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Last Updated

May 5, 2026

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

August 12, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Mind-Body InterventionFibromyalgiachronic painpain managementpost-isometric relaxationproprioceptive neuromuscular facilitationphysical therapy techniquesrandomized controlled trialyogamindfulness

Outcome Measures

Primary Outcomes (1)

  • Disability, Fibromyalgia Impact Questionnaire (FIQ)

    The FIQ is a valid and reliable questionnaire with a total score range of 0-100 measuring overall disease severity, pain severity, physical functioning, work difficulties, morning fatigue, depression, anxiety, and general well-being rated by individuals with fibromyalgia. Higher scores indicate a greater impact of symptoms.

    At baseline (Week 0) and after 8 weeks of intervention (Week 8)

Secondary Outcomes (6)

  • Central Nervous System Assessment, Central Sensitization Inventory (CSI)

    At baseline (Week 0) and after 8 weeks of intervention (Week 8)

  • Autonomic Nervous System Assessment, Heart Rate Variability (HRV)

    At baseline (Week 0) and after 8 weeks of intervention (Week 8)

  • Pain Perception, The Visual Analog Scale (VAS)

    At baseline (Week 0) and after 8 weeks of intervention (Week 8)

  • Fatique Assessment, The 20-item Multidimensional Fatigue Index (MFI)

    At Baseline (Week 0) and after 8 weeks of intervention (Week 8)

  • Sleep Assessment, Pittsburgh Sleep Quality Index (PSQI)

    At baseline (Week 0) and after 8 weeks of intervention (Week 8)

  • +1 more secondary outcomes

Other Outcomes (3)

  • Demographic Data

    At Baseline (Week 0)

  • Adverse Events

    At weeks 2, 4, 6, 8

  • Adherence to the intervention

    At weeks 2, 4, 6, 8

Study Arms (2)

PhYoMind Intervention Group

EXPERIMENTAL

Physiotherapy techniques integrated with yoga and mindfulness + Home Exercise

Other: PhYoMind

Home Exercise Group

ACTIVE COMPARATOR

Only Home Exercise (walking + strenghtening + streching)

Other: Exercise

Interventions

This integrative intervention method includes some specific physiotherapy techniques, ( e. g. self proprioceptive neuromuscular facilitation, self nerve gliding, self mobility, post isometric relaxation techniques) yoga postures, left nostril breathing, humming bee breathing and mindfulness practices. Each session will be 75 minutes and focus on different parts of the body and yoga postures will be selected according to these focused areas. For each week, a specific body area will be chosen as the focus. For example, the first week will focus on the hip area and lower extremities, the second week on the upper body and upper extremities, the third week on the core and anterior line of the body, and the fourth week on the back and posterior line of the body and this sequence will continue through the eighth week. In addition to these sessions, participants in this group will also apply home exercises (aerobic+strenghtening+streching) twice a week, 60 minutes per practice.

PhYoMind Intervention Group

The control group will receive only home exercises twice a week. Big muscle groups strengthening and stretching exercises and walking planned for the patient will be given as home exercise. The walking exercise will last 30 minutes at a moderately fast pace, depending on the subject's adaptation. The strengthening exercises will last 15 minutes and will consist of 3 sets of 12 repetitions of exercises with body weight and light weights, generally targeting the back extensor muscles, core stabilization muscles, shoulder region muscles in the upper extremity and hip and knee joint muscles in the lower extremity. The stretching exercises will last 15 minutes and will include neck muscles, pectoralis major/minor, erector spina, hamstrings, quadriceps femoris muscles 1-2 times for 30 seconds each. Participants will be taught face to face with a brochure when they come for the first assessment and will be asked to do HE at home.

Home Exercise Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Presence of clinically diagnosed fibromyalgia according to the American College of Rheumatology

You may not qualify if:

  • Other important causes of pain other than FM
  • Severe osteoarthritis that affects activities of daily living
  • Severe somatic or psychiatric disorders
  • Receiving another physiotherapy and/or physical exercise treatment concurrently with this study
  • Practicing yoga and/or mindfulness regularly
  • Not having sufficient cognitive level or not being able to participate in the sessions.
  • History of acute myocardial infarction or heart failure and resulting cardiac capacity limitations.
  • Uncontrolled hypertension (resting systolic/diastolic blood pressure ≥160/100 mmHg)
  • Current treatment with medications known to significantly affect HRV (e.g. beta-blockers or antiarrhythmic drugs)
  • Pregnancy or planned pregnancy during the study period
  • Severe psychiatric disorders or insufficient cognitive abilities resulting in inability to participate in the study
  • Participants must either be on a stable treatment for fibromyalgia or not receiving any treatment, with no intention to alter their treatment plan during the study period. Those who do not meet this criterion will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bosch Health Campus

Stuttgart, Auerbachstraße 112, 70376, Germany

Location

Related Publications (1)

  • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. Epub 2016 Aug 30.

    PMID: 27916278BACKGROUND

MeSH Terms

Conditions

FibromyalgiaChronic PainAgnosia

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral Manifestations

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Holger Cramer, Prof. Dr.

    Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Data analysis will also be conducted blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1:1 ratio
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2025

First Posted

August 28, 2025

Study Start

February 10, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

May 30, 2026

Last Updated

May 5, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Due to concerns regarding participant confidentiality and data privacy, as well as compliance with ethical approval and consent agreements, individual participant data will not be shared beyond the study team.

Locations